Loading...
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
IMPORTANCE: Tumor resistance is an emerging problem for Smoothened (SMO) inhibitor–treated metastatic basal cell carcinoma (BCC). Arsenic trioxide and itraconazole antagonize the hedgehog (HH) pathway at sites distinct from those treated by SMO inhibitors. OBJECTIVE: To determine whether administrat...
Na minha lista:
Udgivet i: | JAMA Dermatol |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833646/ https://ncbi.nlm.nih.gov/pubmed/26765315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2015.5473 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|